NPTX1 and Alzheimer disease: The results indicated that the expression of NPTX-1 in the AD + baicalin group was significantly reduced compared to the AD group (0.05953 ± 0.00603 vs 0.07076 ± 0.00788, P = 0.000) (Figure 4a–d).